These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
367 related articles for article (PubMed ID: 23008334)
1. Induction of tumoricidal function in CD4+ T cells is associated with concomitant memory and terminally differentiated phenotype. Hirschhorn-Cymerman D; Budhu S; Kitano S; Liu C; Zhao F; Zhong H; Lesokhin AM; Avogadri-Connors F; Yuan J; Li Y; Houghton AN; Merghoub T; Wolchok JD J Exp Med; 2012 Oct; 209(11):2113-26. PubMed ID: 23008334 [TBL] [Abstract][Full Text] [Related]
2. CD134 plus CD137 dual costimulation induces Eomesodermin in CD4 T cells to program cytotoxic Th1 differentiation. Qui HZ; Hagymasi AT; Bandyopadhyay S; St Rose MC; Ramanarasimhaiah R; Ménoret A; Mittler RS; Gordon SM; Reiner SL; Vella AT; Adler AJ J Immunol; 2011 Oct; 187(7):3555-64. PubMed ID: 21880986 [TBL] [Abstract][Full Text] [Related]
3. Tumor-specific CD4+ T cells maintain effector and memory tumor-specific CD8+ T cells. Church SE; Jensen SM; Antony PA; Restifo NP; Fox BA Eur J Immunol; 2014 Jan; 44(1):69-79. PubMed ID: 24114780 [TBL] [Abstract][Full Text] [Related]
4. Role of T-bet, the master regulator of Th1 cells, in the cytotoxicity of murine CD4 Eshima K; Misawa K; Ohashi C; Iwabuchi K Microbiol Immunol; 2018 May; 62(5):348-356. PubMed ID: 29577371 [TBL] [Abstract][Full Text] [Related]
5. Ox40 costimulation enhances the development of T cell responses induced by dendritic cells in vivo. De Smedt T; Smith J; Baum P; Fanslow W; Butz E; Maliszewski C J Immunol; 2002 Jan; 168(2):661-70. PubMed ID: 11777959 [TBL] [Abstract][Full Text] [Related]
6. Augmentation versus inhibition: effects of conjunctional OX-40 receptor monoclonal antibody and IL-2 treatment on adoptive immunotherapy of advanced tumor. Kjaergaard J; Peng L; Cohen PA; Drazba JA; Weinberg AD; Shu S J Immunol; 2001 Dec; 167(11):6669-77. PubMed ID: 11714839 [TBL] [Abstract][Full Text] [Related]
7. C-C chemokine receptor 4 expression defines a major subset of circulating nonintestinal memory T cells of both Th1 and Th2 potential. Andrew DP; Ruffing N; Kim CH; Miao W; Heath H; Li Y; Murphy K; Campbell JJ; Butcher EC; Wu L J Immunol; 2001 Jan; 166(1):103-11. PubMed ID: 11123282 [TBL] [Abstract][Full Text] [Related]
8. Growth and differentiation advantages of CD4+ OX40+ T cells from allogeneic hematopoietic stem cell transplantation recipients. Shindo T; Ishikawa T; Fukunaga A; Hori T; Uchiyama T Biol Blood Marrow Transplant; 2008 Mar; 14(3):268-81. PubMed ID: 18275893 [TBL] [Abstract][Full Text] [Related]
9. Combined targeting of costimulatory (OX40) and coinhibitory (CTLA-4) pathways elicits potent effector T cells capable of driving robust antitumor immunity. Redmond WL; Linch SN; Kasiewicz MJ Cancer Immunol Res; 2014 Feb; 2(2):142-53. PubMed ID: 24778278 [TBL] [Abstract][Full Text] [Related]
10. Increased frequency of suppressive regulatory T cells and T cell-mediated antigen loss results in murine melanoma recurrence. Jensen SM; Twitty CG; Maston LD; Antony PA; Lim M; Hu HM; Petrausch U; Restifo NP; Fox BA J Immunol; 2012 Jul; 189(2):767-76. PubMed ID: 22723522 [TBL] [Abstract][Full Text] [Related]
11. OX40 signals during priming on dendritic cells inhibit CD4 T cell proliferation: IL-4 switches off OX40 signals enabling rapid proliferation of Th2 effectors. Kim MY; Bekiaris V; McConnell FM; Gaspal FM; Raykundalia C; Lane PJ J Immunol; 2005 Feb; 174(3):1433-7. PubMed ID: 15661901 [TBL] [Abstract][Full Text] [Related]
12. Eomesodermin Expression in CD4+ T Cells Restricts Peripheral Foxp3 Induction. Lupar E; Brack M; Garnier L; Laffont S; Rauch KS; Schachtrup K; Arnold SJ; Guéry JC; Izcue A J Immunol; 2015 Nov; 195(10):4742-52. PubMed ID: 26453746 [TBL] [Abstract][Full Text] [Related]
13. Adoptive transfer of ex vivo-activated memory T-cell subsets with cyclophosphamide provides effective tumor-specific chemoimmunotherapy of advanced metastatic murine melanoma and carcinoma. Gold JE; Zachary DT; Osband ME Int J Cancer; 1995 May; 61(4):580-6. PubMed ID: 7759164 [TBL] [Abstract][Full Text] [Related]
14. The cryo-thermal therapy eradicated melanoma in mice by eliciting CD4 He K; Liu P; Xu LX Cell Death Dis; 2017 Mar; 8(3):e2703. PubMed ID: 28333145 [TBL] [Abstract][Full Text] [Related]
15. Identification of multiple HLA-DR-restricted epitopes of the tumor-associated antigen CAMEL by CD4+ Th1/Th2 lymphocytes. Slager EH; van der Minne CE; Krüse M; Krueger DD; Griffioen M; Osanto S J Immunol; 2004 Apr; 172(8):5095-102. PubMed ID: 15067093 [TBL] [Abstract][Full Text] [Related]
16. Polarized development of memory cell-like IFN-gamma-producing cells in the absence of TCR zeta-chain. Krymskaya L; Lee WH; Zhong L; Liu CP J Immunol; 2005 Feb; 174(3):1188-95. PubMed ID: 15661872 [TBL] [Abstract][Full Text] [Related]
17. CD70 signaling is critical for CD28-independent CD8+ T cell-mediated alloimmune responses in vivo. Yamada A; Salama AD; Sho M; Najafian N; Ito T; Forman JP; Kewalramani R; Sandner S; Harada H; Clarkson MR; Mandelbrot DA; Sharpe AH; Oshima H; Yagita H; Chalasani G; Lakkis FG; Auchincloss H; Sayegh MH J Immunol; 2005 Feb; 174(3):1357-64. PubMed ID: 15661893 [TBL] [Abstract][Full Text] [Related]
18. Requirements for the differentiation of innate T-bet Kawabe T; Yi J; Kawajiri A; Hilligan K; Fang D; Ishii N; Yamane H; Zhu J; Jankovic D; Kim KS; Trinchieri G; Sher A Nat Commun; 2020 Jul; 11(1):3366. PubMed ID: 32632165 [TBL] [Abstract][Full Text] [Related]
19. GILT accelerates autoimmunity to the melanoma antigen tyrosinase-related protein 1. Rausch MP; Irvine KR; Antony PA; Restifo NP; Cresswell P; Hastings KT J Immunol; 2010 Sep; 185(5):2828-35. PubMed ID: 20668223 [TBL] [Abstract][Full Text] [Related]
20. Constitutive expression of CIITA directs CD4 T cells to produce Th2 cytokines in the thymus. Patel DR; Li W; Park JS; Sofi MH; Gourley TS; Hangoc G; Kaplan MH; Chang CH Cell Immunol; 2005 Jan; 233(1):30-40. PubMed ID: 15876426 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]